S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CLRB Cellectar Biosciences Inc

0.2681

0.0081 (3.12%)

Last Updated: 11:15:20

Delayed by 15 minutes

Form 8-K - Current report

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences Inc News

Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Wednesday 5 February 2025 (4 hours ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Monday 3 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 January 2025 (5 days ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Wednesday 29 January 2025 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference
Sunday 12 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring
Tuesday 10 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 18 November 2024 (3 months ago) • Edgar (US Regulatory)

Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
Monday 18 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 18 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

More Cellectar Biosciences Inc News Articles

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions